[Application of Nano-drug Delivery Technology in Overcoming Drug Resistance 
in Lung Cancer]

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Lung cancer presents a significant global health challenge, particularly in China, with high mortality rates.
• Drug resistance is a major obstacle in lung cancer treatment, leading to poor patient outcomes.
• Conventional therapies often struggle to overcome the complexities of lung cancer drug resistance.

Purpose of the Study:

• To review the current landscape of lung cancer treatment and drug resistance mechanisms.
• To explore the application of nanotechnology and nano-drug delivery systems in combating lung cancer drug resistance.
• To summarize recent advancements and future prospects of nano-drug delivery in lung cancer therapy.

Main Methods:

• Literature review of lung cancer treatment strategies.
• Analysis of drug resistance mechanisms in lung cancer.
• Examination of nano-drug delivery technologies and their role in overcoming resistance.
• Synthesis of recent research findings on nanotechnology applications in lung cancer.

Main Results:

• Nano-drug delivery systems show potential for combined drug delivery, increased efficiency, and improved targeting.
• Nanotechnology offers enhanced safety profiles for drug administration in lung cancer.
• Targeting specific drug resistance mechanisms is a key advantage of nano-drug delivery.

Conclusions:

• Nano-drug delivery technology represents a significant advancement in overcoming lung cancer drug resistance.
• Further research and development are needed to address the challenges and fully realize the potential of nano-drug delivery systems.
• Nanotechnology holds promise for improving the efficacy and safety of lung cancer treatments.